109 related articles for article (PubMed ID: 9240248)
21. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles.
Lanzone A; Fulghesu AM; Villa P; Guida C; Guido M; Nicoletti MC; Caruso A; Mancuso S
Fertil Steril; 1994 Jul; 62(1):35-41. PubMed ID: 8005301
[TBL] [Abstract][Full Text] [Related]
22. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
23. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
Ellenbogen A; David H; Libal Y; Ballas S
Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
[TBL] [Abstract][Full Text] [Related]
24. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
[TBL] [Abstract][Full Text] [Related]
25. Unexplained infertility: evaluation of the luteal phase; results of the National Center for Infertility Research at Michigan.
Blacker CM; Ginsburg KA; Leach RE; Randolph J; Moghissi KS
Fertil Steril; 1997 Mar; 67(3):437-42. PubMed ID: 9091327
[TBL] [Abstract][Full Text] [Related]
26. Altered luteinizing hormone pulse frequency in early follicular phase of the menstrual cycle with luteal phase defect patients in women.
Suh BY; Betz G
Fertil Steril; 1993 Nov; 60(5):800-5. PubMed ID: 8224264
[TBL] [Abstract][Full Text] [Related]
27. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation.
Ubaldi FM; Capalbo A; Vaiarelli A; Cimadomo D; Colamaria S; Alviggi C; Trabucco E; Venturella R; Vajta G; Rienzi L
Fertil Steril; 2016 Jun; 105(6):1488-1495.e1. PubMed ID: 27020168
[TBL] [Abstract][Full Text] [Related]
28. Atrial natriuretic peptide, oestradiol and progesterone in women undergoing spontaneous and gonadotrophin-stimulated ovulatory cycles.
Yeko TR; Rao PS; Parsons AK; Mayer JC; Graham LB; Maroulis GB
Hum Reprod; 1995 Nov; 10(11):2872-4. PubMed ID: 8747035
[TBL] [Abstract][Full Text] [Related]
29. Analysis of hormonal changes during combined buserelin/HMG treatment.
Urbancsek J; Rabe T; Grunwald K; Kiesel L; Runnebaum B
Hum Reprod; 1990 Aug; 5(6):675-81. PubMed ID: 2123882
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
[TBL] [Abstract][Full Text] [Related]
31. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
[TBL] [Abstract][Full Text] [Related]
32. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
33. The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: Is it hypoandrogenic?
de los Santos MJ; García-Laez V; Beltrán D; Labarta E; Zuzuarregui JL; Alamá P; Gámiz P; Crespo J; Bosch E; Pellicer A
Hum Reprod; 2013 Jan; 28(1):224-9. PubMed ID: 23019297
[TBL] [Abstract][Full Text] [Related]
34. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein-cholesterol levels in infertile women with luteal phase deficiency.
Hansen KK; Knopp RH; Soules MR
Fertil Steril; 1991 May; 55(5):916-21. PubMed ID: 2022269
[TBL] [Abstract][Full Text] [Related]
36. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
[TBL] [Abstract][Full Text] [Related]
37. Luteal function following ovarian stimulation in rhesus monkeys for in vitro fertilization: atypical response to human chorionic gonadotropin treatment simulating early pregnancy.
VandeVoort CA; Hess DL; Stouffer RL
Fertil Steril; 1988 Jun; 49(6):1071-5. PubMed ID: 3131158
[TBL] [Abstract][Full Text] [Related]
38. Pulsatility of serum-luteinizing hormone during hyperstimulation with clomiphene citrate and human menopausal gonadotropin for in vitro fertilization.
Wolfram J; Siegberg R; Apter D; Alfthan H; Stenman UH; Laatikainen T
Fertil Steril; 1989 Nov; 52(5):817-20. PubMed ID: 2509253
[TBL] [Abstract][Full Text] [Related]
39. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
